Cargando…
Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
Background: Platelet reactivity is closely associated with adverse events in percutaneous coronary intervention (PCI) patients. Inflammation plays a crucial role in the development of coronary heart disease (CHD). Aim: To investigate the association of inflammatory biomarkers such as leukocyte count...
Autores principales: | Li, Jiawen, Yuan, Deshan, Jiang, Lin, Tang, Xiaofang, Xu, Jingjing, Song, Ying, Chen, Jue, Qiao, Shubin, Yang, Yuejin, Gao, Runlin, Xu, Bo, Yuan, Jinqing, Zhao, Xueyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521006/ https://www.ncbi.nlm.nih.gov/pubmed/34671655 http://dx.doi.org/10.3389/fcvm.2021.736466 |
Ejemplares similares
-
D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2020) -
Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023) -
A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023) -
Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021) -
Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
por: Yan, Kailun, et al.
Publicado: (2023)